# Maplebear Inc.: financial statements, quarterly

CART · Nasdaq · CIK 1579091 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cart.md) · [Financials](/companies/cart/financials.md) · [Filings](/companies/cart/filings.md) · [Insiders](/companies/cart/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cart/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [764](/filings/0001579091-24-000103.md) | [803 d](/filings/0001579091-26-000018.md) | [820](/filings/0001579091-25-000048.md) | [823](/filings/0001579091-25-000067.md) | [852](/filings/0001579091-25-000097.md) | [883 d](/filings/0001579091-26-000018.md) | [897](/filings/0001579091-26-000036.md) | [914](/filings/0001579091-26-000042.md) | [939](/filings/0001579091-25-000097.md) | [992 d](/filings/0001579091-26-000018.md) | [1,019](/filings/0001579091-26-000036.md) | [1,043](/filings/0001579091-26-000042.md) |
| Cost of revenue | $m | [203](/filings/0001579091-24-000103.md) | [195 d](/filings/0001579091-26-000018.md) | [206](/filings/0001579091-25-000048.md) | [200](/filings/0001579091-25-000067.md) | [211](/filings/0001579091-25-000097.md) | [219 d](/filings/0001579091-26-000018.md) | [226](/filings/0001579091-26-000036.md) | [236](/filings/0001579091-26-000042.md) | [247](/filings/0001579091-25-000097.md) | [275 d](/filings/0001579091-26-000018.md) | [281](/filings/0001579091-26-000036.md) | [292](/filings/0001579091-26-000042.md) |
| Gross profit | $m | [561](/filings/0001579091-24-000103.md) | [608 d](/filings/0001579091-26-000018.md) | [614](/filings/0001579091-25-000048.md) | [623](/filings/0001579091-25-000067.md) | [641](/filings/0001579091-25-000097.md) | [664 d](/filings/0001579091-26-000018.md) | [671](/filings/0001579091-26-000036.md) | [678](/filings/0001579091-26-000042.md) | [692](/filings/0001579091-25-000097.md) | [717 d](/filings/0001579091-26-000018.md) | [738](/filings/0001579091-26-000036.md) | [751](/filings/0001579091-26-000042.md) |
| Research and development | $m | [1,850](/filings/0001579091-24-000103.md) | [205 d](/filings/0001579091-26-000018.md) | [115](/filings/0001579091-25-000048.md) | [185](/filings/0001579091-25-000067.md) | [149](/filings/0001579091-25-000097.md) | [155 d](/filings/0001579091-26-000018.md) | [144](/filings/0001579091-26-000036.md) | [166](/filings/0001579091-26-000042.md) | [169](/filings/0001579091-25-000097.md) | [171 d](/filings/0001579091-26-000018.md) | [164](/filings/0001579091-26-000036.md) | [202](/filings/0001579091-26-000042.md) |
| Operating income | $m | [(2,457)](/filings/0001579091-24-000103.md) | [46.0 d](/filings/0001579091-26-000018.md) | [144](/filings/0001579091-25-000048.md) | [52.0](/filings/0001579091-25-000067.md) | [138](/filings/0001579091-25-000097.md) | [155 d](/filings/0001579091-26-000018.md) | [110](/filings/0001579091-26-000036.md) | [124](/filings/0001579091-26-000042.md) | [166](/filings/0001579091-25-000097.md) | [97.0 d](/filings/0001579091-26-000018.md) | [182](/filings/0001579091-26-000036.md) | [143](/filings/0001579091-26-000042.md) |
| Income tax | $m | [(440)](/filings/0001579091-24-000103.md) | [(63.0) d](/filings/0001579091-26-000018.md) | [35.0](/filings/0001579091-25-000048.md) | [7.0](/filings/0001579091-25-000067.md) | [35.0](/filings/0001579091-25-000097.md) | [18.0 d](/filings/0001579091-26-000018.md) | [18.0](/filings/0001579091-26-000036.md) | [26.0](/filings/0001579091-26-000042.md) | [37.0](/filings/0001579091-25-000097.md) | [28.0 d](/filings/0001579091-26-000018.md) | [44.0](/filings/0001579091-26-000036.md) | [36.0](/filings/0001579091-26-000042.md) |
| Net income | $m | [(1,999)](/filings/0001579091-24-000103.md) | [135 d](/filings/0001579091-26-000018.md) | [130](/filings/0001579091-25-000097.md) | [61.0](/filings/0001579091-25-000097.md) | [118](/filings/0001579091-25-000097.md) | [148 d](/filings/0001579091-26-000018.md) | [106](/filings/0001579091-26-000042.md) | [116](/filings/0001579091-26-000042.md) | [144](/filings/0001579091-25-000097.md) | [81.0 d](/filings/0001579091-26-000018.md) | [144](/filings/0001579091-26-000042.md) | [111](/filings/0001579091-26-000042.md) |
| Diluted EPS | $ per share | [(20.86)](/filings/0001579091-24-000103.md) | not reported | [0.43](/filings/0001579091-25-000048.md) | [0.20](/filings/0001579091-25-000067.md) | [0.42](/filings/0001579091-25-000097.md) | not reported | [0.37](/filings/0001579091-26-000036.md) | [0.41](/filings/0001579091-26-000042.md) | [0.51](/filings/0001579091-25-000097.md) | not reported | [0.57](/filings/0001579091-26-000036.md) | [0.45](/filings/0001579091-26-000042.md) |
| Basic EPS | $ per share | [(20.86)](/filings/0001579091-24-000103.md) | not reported | [0.47](/filings/0001579091-25-000048.md) | [0.22](/filings/0001579091-25-000067.md) | [0.45](/filings/0001579091-25-000097.md) | not reported | [0.40](/filings/0001579091-26-000036.md) | [0.43](/filings/0001579091-26-000042.md) | [0.54](/filings/0001579091-25-000097.md) | not reported | [0.59](/filings/0001579091-26-000036.md) | [0.46](/filings/0001579091-26-000042.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2,010](/filings/0001579091-24-000103.md) | [2,137](/filings/0001579091-26-000018.md) | [1,514](/filings/0001579091-25-000048.md) | [1,434](/filings/0001579091-25-000067.md) | [1,288](/filings/0001579091-25-000097.md) | [1,278](/filings/0001579091-26-000018.md) | [1,558](/filings/0001579091-26-000036.md) | [1,489](/filings/0001579091-26-000042.md) | [1,690](/filings/0001579091-25-000097.md) | [637](/filings/0001579091-26-000042.md) | [631](/filings/0001579091-26-000036.md) | [757](/filings/0001579091-26-000042.md) |
| Current assets | $m | [3,073](/filings/0001579091-23-000013.md) | [3,305](/filings/0001579091-25-000015.md) | [2,707](/filings/0001579091-24-000064.md) | [2,585](/filings/0001579091-24-000087.md) | [2,509](/filings/0001579091-24-000103.md) | [2,697](/filings/0001579091-26-000018.md) | [2,873](/filings/0001579091-25-000048.md) | [2,890](/filings/0001579091-25-000067.md) | [3,031](/filings/0001579091-25-000097.md) | [2,199](/filings/0001579091-26-000042.md) | [2,091](/filings/0001579091-26-000036.md) | [2,117](/filings/0001579091-26-000042.md) |
| Total assets | $m | [4,421](/filings/0001579091-23-000013.md) | [4,727](/filings/0001579091-25-000015.md) | [4,097](/filings/0001579091-24-000064.md) | [4,027](/filings/0001579091-24-000087.md) | [3,926](/filings/0001579091-24-000103.md) | [4,115](/filings/0001579091-26-000018.md) | [4,292](/filings/0001579091-25-000048.md) | [4,433](/filings/0001579091-25-000067.md) | [4,540](/filings/0001579091-25-000097.md) | [3,687](/filings/0001579091-26-000042.md) | [3,535](/filings/0001579091-26-000036.md) | [3,510](/filings/0001579091-26-000042.md) |
| Current liabilities | $m | [683](/filings/0001579091-23-000013.md) | [733](/filings/0001579091-25-000015.md) | [716](/filings/0001579091-24-000064.md) | [750](/filings/0001579091-24-000087.md) | [820](/filings/0001579091-24-000103.md) | [798](/filings/0001579091-26-000018.md) | [887](/filings/0001579091-25-000048.md) | [871](/filings/0001579091-25-000067.md) | [832](/filings/0001579091-25-000097.md) | [917](/filings/0001579091-26-000042.md) | [885](/filings/0001579091-26-000036.md) | [929](/filings/0001579091-26-000042.md) |
| Total liabilities | $m | [762](/filings/0001579091-23-000013.md) | [800](/filings/0001579091-25-000015.md) | [777](/filings/0001579091-24-000064.md) | [806](/filings/0001579091-24-000087.md) | [870](/filings/0001579091-24-000103.md) | [836](/filings/0001579091-26-000018.md) | [928](/filings/0001579091-25-000048.md) | [942](/filings/0001579091-25-000067.md) | [889](/filings/0001579091-25-000097.md) | [974](/filings/0001579091-26-000042.md) | [941](/filings/0001579091-26-000036.md) | [988](/filings/0001579091-26-000042.md) |
| Shareholders' equity | $m | [3,484](/filings/0001579091-24-000103.md) | [3,750](/filings/0001579091-26-000018.md) | [3,141](/filings/0001579091-25-000097.md) | [3,039](/filings/0001579091-25-000097.md) | [2,872](/filings/0001579091-25-000097.md) | [3,093](/filings/0001579091-26-000042.md) | [3,176](/filings/0001579091-26-000042.md) | [3,299](/filings/0001579091-26-000042.md) | [3,458](/filings/0001579091-25-000097.md) | [2,518](/filings/0001579091-26-000042.md) | [2,395](/filings/0001579091-26-000042.md) | [2,322](/filings/0001579091-26-000042.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [111 d](/filings/0001579091-24-000103.md) | [233 d](/filings/0001579091-26-000018.md) | [105](/filings/0001579091-25-000048.md) | [244 d](/filings/0001579091-25-000067.md) | [185 d](/filings/0001579091-25-000097.md) | [153 d](/filings/0001579091-26-000018.md) | [298](/filings/0001579091-26-000036.md) | [203 d](/filings/0001579091-26-000042.md) | [287 d](/filings/0001579091-25-000097.md) | [183 d](/filings/0001579091-26-000018.md) | [268](/filings/0001579091-26-000036.md) | [494 d](/filings/0001579091-26-000042.md) |
| Capital expenditure | $m | [16.0 d](/filings/0001579091-24-000103.md) | [16.0 d](/filings/0001579091-26-000018.md) | [14.0](/filings/0001579091-25-000048.md) | [24.0 d](/filings/0001579091-25-000067.md) | [14.0 d](/filings/0001579091-25-000097.md) | [12.0 d](/filings/0001579091-26-000018.md) | [18.0](/filings/0001579091-26-000036.md) | [16.0 d](/filings/0001579091-26-000042.md) | [15.0 d](/filings/0001579091-25-000097.md) | [12.0 d](/filings/0001579091-26-000018.md) | [16.0](/filings/0001579091-26-000036.md) | [13.0 d](/filings/0001579091-26-000042.md) |
| Share repurchases | $m | [0.0 d](/filings/0001579091-24-000103.md) | [36.0 d](/filings/0001579091-26-000018.md) | [715](/filings/0001579091-25-000048.md) | [325 d](/filings/0001579091-25-000067.md) | [357 d](/filings/0001579091-25-000097.md) | [5.0 d](/filings/0001579091-26-000018.md) | [89.0](/filings/0001579091-26-000036.md) | [121 d](/filings/0001579091-26-000042.md) | [62.0 d](/filings/0001579091-25-000097.md) | [1,114 d](/filings/0001579091-26-000018.md) | [359](/filings/0001579091-26-000036.md) | [324 d](/filings/0001579091-26-000042.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | period not labelled (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [72.0](/filings/0001579091-23-000013.md) | [72.2](/filings/0001579091-24-000064.md) | [72.3](/filings/0001579091-24-000087.md) | [95.8](/filings/0001579091-24-000103.md) | [302](/filings/0001579091-25-000048.md) | [286](/filings/0001579091-25-000067.md) | [281](/filings/0001579091-25-000097.md) | [277](/filings/0001579091-26-000036.md) | [281](/filings/0001579091-26-000042.md) | [283](/filings/0001579091-25-000097.md) | [254](/filings/0001579091-26-000036.md) | [249](/filings/0001579091-26-000042.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 231,500,067 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001579091-26-000042.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.